TapewireFind a company

person · Reporting owner

SORIANO JOHN

Disclosed activity across 1 company

Tapewire entity
135623
SEC CIK
0001740947

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
INSMED IncINSM · Entity 3174Chief Compliance OfficerSeptember 07, 2021September 09, 2021

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

INSMED Inc

Report date September 07, 2021 · Filed September 09, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect35,204 Ending reported balance After 2021-09-07 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2021-09-07 · Exercise / conversion · Acquired 17,349 · Balance 52,553

Row 2 · 2021-09-07 · Sale · Disposed 17,349 · Balance 35,204

F1: This is the weighted average sales price representing the shares sold at prices ranging from $28.11 to $28.37 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.91 · Expires 2029-01-03Direct52,046 Reported balance After 2021-09-07 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2021-09-07 · Exercise / conversion · Disposed 17,349 · Balance 52,046

F2: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Filing footnotes · ownership attribution and instrument terms

F1: This is the weighted average sales price representing the shares sold at prices ranging from $28.11 to $28.37 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F2: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
September 07, 2021 Filed Sep 9, 2021 20:10 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionStock Option (right to buy) · Derivative 17,349 $0.00 Strike: $13.91 $0.00
Disclosure

SEC source: 0001140361-21-030808 · form4.xml · derivative · entry 3

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,046

Underlying: Common Stock · 17,349 shares

Expires 2029-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
September 07, 2021 Filed Sep 9, 2021 20:10 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 17,349 $28.20 $489,241.80
Disclosure

SEC source: 0001140361-21-030808 · form4.xml · nonDerivative · entry 2

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,204

F1 · price: This is the weighted average sales price representing the shares sold at prices ranging from $28.11 to $28.37 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
September 07, 2021 Filed Sep 9, 2021 20:10 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionCommon Stock 17,349 $13.91 $241,324.59
Disclosure

SEC source: 0001140361-21-030808 · form4.xml · nonDerivative · entry 1

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,553

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2021 Filed May 18, 2021 20:48 UTC INSMED Inc INSM · Entity 3174 Tax withholdingCommon Stock 1,655 $26.23 $43,410.65
Disclosure

SEC source: 0001140361-21-017901 · form4.xml · nonDerivative · entry 1

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,204

F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units.

Read SEC document
May 12, 2021 Filed May 14, 2021 20:54 UTC INSMED Inc INSM · Entity 3174 GrantStock Option (right to buy) · Derivative 34,320 $0.00 Strike: $26.46 $0.00
Disclosure

SEC source: 0001140361-21-017440 · form4.xml · derivative · entry 2

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,320

Underlying: Common Stock · 34,320 shares

Expires 2031-05-12

F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
May 12, 2021 Filed May 14, 2021 20:54 UTC INSMED Inc INSM · Entity 3174 GrantCommon Stock 7,086 Not disclosed Not disclosed
Disclosure

SEC source: 0001140361-21-017440 · form4.xml · nonDerivative · entry 1

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,859

F1 · shares: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on May 12, 2021, for no consideration.

Read SEC document
March 11, 2021 Filed Mar 12, 2021 21:20 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionStock Option (right to buy) · Derivative 23,717 $0.00 Strike: $30.86 $0.00
Disclosure

SEC source: 0001140361-21-008324 · form4.xml · derivative · entry 3

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,550

Underlying: Common Stock · 23,717 shares

Expires 2028-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
March 11, 2021 Filed Mar 12, 2021 21:20 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 23,717 $40.00 $948,680.00
Disclosure

SEC source: 0001140361-21-008324 · form4.xml · nonDerivative · entry 2

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,773

F1 · price: This is the weighted average sales price representing the shares sold at prices ranging from $40.00 to $40.01 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
March 11, 2021 Filed Mar 12, 2021 21:20 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionCommon Stock 23,717 $30.86 $731,906.62
Disclosure

SEC source: 0001140361-21-008324 · form4.xml · nonDerivative · entry 1

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,490

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 10, 2021 Filed Mar 11, 2021 21:12 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionStock Option (right to buy) · Derivative 500 $0.00 Strike: $30.86 $0.00
Disclosure

SEC source: 0001140361-21-008183 · form4.xml · derivative · entry 12

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,267

Underlying: Common Stock · 500 shares

Expires 2028-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
March 10, 2021 Filed Mar 11, 2021 21:12 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 500 $40.00 $20,000.00
Disclosure

SEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 8

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,773

F2 · price: This is the weighted average sales price representing the shares sold at prices ranging from $40.00 to $40.01 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
March 10, 2021 Filed Mar 11, 2021 21:12 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionCommon Stock 500 $30.86 $15,430.00
Disclosure

SEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 7

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,273

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 09, 2021 Filed Mar 11, 2021 21:12 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionStock Option (right to buy) · Derivative 14,130 $0.00 Strike: $23.75 $0.00
Disclosure

SEC source: 0001140361-21-008183 · form4.xml · derivative · entry 11

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,390

Underlying: Common Stock · 14,130 shares

Expires 2030-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
March 09, 2021 Filed Mar 11, 2021 21:12 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionStock Option (right to buy) · Derivative 17,349 $0.00 Strike: $13.91 $0.00
Disclosure

SEC source: 0001140361-21-008183 · form4.xml · derivative · entry 10

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,395

Underlying: Common Stock · 17,349 shares

Expires 2029-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
March 09, 2021 Filed Mar 11, 2021 21:12 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionStock Option (right to buy) · Derivative 13,433 $0.00 Strike: $30.86 $0.00
Disclosure

SEC source: 0001140361-21-008183 · form4.xml · derivative · entry 9

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,767

Underlying: Common Stock · 13,433 shares

Expires 2028-01-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
March 09, 2021 Filed Mar 11, 2021 21:12 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 14,130 $40.38 $570,569.40
Disclosure

SEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 6

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,773

F1 · price: This is the weighted average sales price representing the shares sold at prices ranging from $40.00 to $40.61 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
March 09, 2021 Filed Mar 11, 2021 21:12 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionCommon Stock 14,130 $23.75 $335,587.50
Disclosure

SEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 5

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,903

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 09, 2021 Filed Mar 11, 2021 21:12 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 17,349 $40.38 $700,552.62
Disclosure

SEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 4

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,773

F1 · price: This is the weighted average sales price representing the shares sold at prices ranging from $40.00 to $40.61 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
March 09, 2021 Filed Mar 11, 2021 21:12 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionCommon Stock 17,349 $13.91 $241,324.59
Disclosure

SEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 3

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,122

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 09, 2021 Filed Mar 11, 2021 21:12 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 13,433 $40.38 $542,424.54
Disclosure

SEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 2

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,773

F1 · price: This is the weighted average sales price representing the shares sold at prices ranging from $40.00 to $40.61 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
March 09, 2021 Filed Mar 11, 2021 21:12 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionCommon Stock 13,433 $30.86 $414,542.38
Disclosure

SEC source: 0001140361-21-008183 · form4.xml · nonDerivative · entry 1

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,206

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 07, 2021 Filed Jan 8, 2021 21:37 UTC INSMED Inc INSM · Entity 3174 GrantStock Option (right to buy) · Derivative 27,360 $0.00 Strike: $34.03 $0.00
Disclosure

SEC source: 0001104659-21-002505 · tm211774-8_4seq1.xml · derivative · entry 2

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,360

Underlying: Common Stock · 27,360 shares

Expires 2031-01-07

F3 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
January 07, 2021 Filed Jan 8, 2021 21:37 UTC INSMED Inc INSM · Entity 3174 GrantCommon Stock 5,509 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-21-002505 · tm211774-8_4seq1.xml · nonDerivative · entry 1

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,773

F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.

F2 · price: Each Restricted Stock Unit was received as a grant on January 7, 2021, for no consideration, and represents a contingent right to receive one share of Common Stock.

Read SEC document
January 03, 2021 Filed Jan 6, 2021 22:13 UTC INSMED Inc INSM · Entity 3174 Tax withholdingCommon Stock 949 $33.29 $31,592.21
Disclosure

SEC source: 0001104659-21-001606 · tm211774d5_4seq1.xml · nonDerivative · entry 1

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,264

F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of time-based restricted stock units.

Read SEC document
August 10, 2020 Filed Aug 12, 2020 21:17 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionStock Option (right to buy) · Derivative 52,046 $0.00 Strike: $13.91 $0.00
Disclosure

SEC source: 0001104659-20-093991 · a4.xml · derivative · entry 4

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,744

Underlying: Common Stock · 52,046 shares

Expires 2029-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
August 10, 2020 Filed Aug 12, 2020 21:17 UTC INSMED Inc INSM · Entity 3174 SaleCommon Stock 52,046 $30.29 $1,576,473.34
Disclosure

SEC source: 0001104659-20-093991 · a4.xml · nonDerivative · entry 3

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,213

F2 · price: This is the weighted average sales price representing 52,046 shares sold at prices ranging from $30.12 to $30.49 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Read SEC document
August 10, 2020 Filed Aug 12, 2020 21:17 UTC INSMED Inc INSM · Entity 3174 Exercise / conversionCommon Stock 52,046 $13.91 $723,959.86
Disclosure

SEC source: 0001104659-20-093991 · a4.xml · nonDerivative · entry 2

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,259

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 15, 2020 Filed Aug 12, 2020 21:17 UTC INSMED Inc INSM · Entity 3174 Tax withholdingCommon Stock 994 $25.46 $25,307.24
Disclosure

SEC source: 0001104659-20-093991 · a4.xml · nonDerivative · entry 1

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,253

F1 · security: Represents the withholding of shares of common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. This transaction was not reported previously due to a clerical error.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 23:14 UTC INSMED Inc INSM · Entity 3174 GrantStock Option (right to buy) · Derivative 56,520 $0.00 Strike: $23.75 $0.00
Disclosure

SEC source: 0001127430-20-000027 · edgar.xml · derivative · entry 2

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,520

Underlying: Common Stock · 56,520 shares

Expires 2030-01-03

F4 · derivative.exercise_date: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document
January 03, 2020 Filed Jan 7, 2020 23:14 UTC INSMED Inc INSM · Entity 3174 GrantCommon Stock 10,526 Not disclosed Not disclosed
Disclosure

SEC source: 0001127430-20-000027 · edgar.xml · nonDerivative · entry 1

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,207

F1 · shares: Restricted stock units granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant for four years.

F2 · price: Each Restricted Stock Unit was received as a grant on January 3, 2020, for no consideration, and represents a contingent right to receive one share of Common Stock.

F3 · balance_after: Includes 2,746 shares acquired through the Company's 2018 Employee Stock Purchase Plan.

Read SEC document
May 15, 2019 Filed May 16, 2019 21:15 UTC INSMED Inc INSM · Entity 3174 GrantCommon Stock 12,935 Not disclosed Not disclosed
Disclosure

SEC source: 0001127430-19-000072 · edgar.xml · nonDerivative · entry 1

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,892

F1 · shares: Restricted stock units granted pursuant to the Company's 2017 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant for four years.

F2 · price: Each Restricted Stock Unit was received as a grant on May 15, 2019, for no consideration, and represents a contingent right to receive one share of Common Stock.

F3 · balance_after: Includes 957 shares acquired through the Company's 2018 Employee Stock Purchase Plan for the six-month period ended December 31, 2018.

Read SEC document
January 03, 2019 Filed Jan 7, 2019 21:10 UTC INSMED Inc INSM · Entity 3174 GrantStock Option · Derivative 138,790 $0.00 Strike: $13.91 $0.00
Disclosure

SEC source: 0001127430-19-000021 · edgar.xml · derivative · entry 1

SORIANO JOHN · CIK 0001740947 · Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,790

Underlying: Common Stock · 138,790 shares

Expires 2029-01-03

F1 · derivative.exercise_date: Stock options granted under the Company's 2017 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty-five percent (25%) on the first anniversary of the grant date and an additional twelve and one-half percent (12.5%) vest on the six month anniversary of the first anniversary date and each six month anniversary date thereafter through the fourth anniversary of the date of grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.